McKee M - Search Results

1

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment.

Harlin H, Meng Y, Peterson AC, Zha Y, Tretiakova M, Slingluff C, McKee M, Gajewski TF. Harlin H, et al. Among authors: mckee m. Cancer Res. 2009 Apr 1;69(7):3077-85. doi: 10.1158/0008-5472.CAN-08-2281. Epub 2009 Mar 17. Cancer Res. 2009. PMID: 19293190 Free PMC article.

2

Antigen recognition and T-cell biology.

Nishimura MI, Roszkowski JJ, Moore TV, Brasic N, McKee MD, Clay TM. Nishimura MI, et al. Among authors: mckee md. Cancer Treat Res. 2005;123:37-59. doi: 10.1007/0-387-27545-2_2. Cancer Treat Res. 2005. PMID: 16211865 Review.

3

CD8-independent tumor cell recognition is a property of the T cell receptor and not the T cell.

Roszkowski JJ, Yu DC, Rubinstein MP, McKee MD, Cole DJ, Nishimura MI. Roszkowski JJ, et al. J Immunol. 2003 Mar 1;170(5):2582-9. doi: 10.4049/jimmunol.170.5.2582. J Immunol. 2003. PMID: 12594285

4

Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells.

Klarquist J, Barfuss A, Kandala S, Reust MJ, Braun RK, Hu J, Dilling DF, McKee MD, Boissy RE, Love RB, Nishimura MI, Le Poole IC. Klarquist J, et al. Am J Pathol. 2009 Dec;175(6):2463-72. doi: 10.2353/ajpath.2009.090525. Epub 2009 Nov 5. Am J Pathol. 2009. PMID: 19893037 Free PMC article.

5

Identification of a hepatitis C virus-reactive T cell receptor that does not require CD8 for target cell recognition.

Callender GG, Rosen HR, Roszkowski JJ, Lyons GE, Li M, Moore T, Brasic N, McKee MD, Nishimura MI. Callender GG, et al. Among authors: mckee md. Hepatology. 2006 May;43(5):973-81. doi: 10.1002/hep.21157. Hepatology. 2006. PMID: 16628627

6

T cell immunotherapy.

McKee MD, Fichera A, Nishimura MI. McKee MD, et al. Front Biosci. 2007 Jan 1;12:919-32. doi: 10.2741/2114. Front Biosci. 2007. PMID: 17127349 Review.

7

Recognition of carcinoembryonic antigen peptide and heteroclitic peptide by peripheral blood T lymphocytes.

Brown ME, Miao H, McKee MD. Brown ME, et al. J Immunother. 2007 Apr;30(3):350-8. doi: 10.1097/CJI.0b013e31802b5005. J Immunother. 2007. PMID: 17414326

8

Targeted therapy for solid tumors: current status.

Zureikat AH, McKee MD. Zureikat AH, et al. Surg Oncol Clin N Am. 2008 Apr;17(2):279-301, vii-viii. doi: 10.1016/j.soc.2008.01.004. Surg Oncol Clin N Am. 2008. PMID: 18375353 Review.

9

T cell avidity and tumor recognition: implications and therapeutic strategies.

McKee MD, Roszkowski JJ, Nishimura MI. McKee MD, et al. J Transl Med. 2005 Sep 20;3:35. doi: 10.1186/1479-5876-3-35. J Transl Med. 2005. PMID: 16174302 Free PMC article.

10

Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation.

Hariharan V, Klarquist J, Reust MJ, Koshoffer A, McKee MD, Boissy RE, Le Poole IC. Hariharan V, et al. J Invest Dermatol. 2010 Jan;130(1):211-20. doi: 10.1038/jid.2009.214. J Invest Dermatol. 2010. PMID: 19657355 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,683 results

Search Page